Alexis Vandier

Alexis Vandier currently serves as Global Asset Lead Oncology at Servier since May 2023. In addition, Alexis holds positions as Advisory Board Member at Parean Biotechnologies and Senior Advisor at both Extens e-santé and BNP Paribas Développement, focusing on investment strategies and innovative programs in health technology. Previous experience includes a leadership role at OSE Immunotherapeutics and extensive tenure at Ipsen, where significant contributions were made as Vice President and General Manager in various capacities, including overseeing the oncology portfolio and corporate strategic planning. Academic achievements include certifications from Harvard Medical School and London Business School, along with degrees in Economics and Sciences from Université Lumière Lyon 2 and Centrale Lyon.